Vireo Growth Inc. (CNSX: VREO)
Health Care · Pharmaceuticals · US
CA$13.37
-2.41% today · -53.1% 1Y
Vireo Growth Inc. (CNSX: VREO) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $457.48M and employs 385 people.
Over the last twelve months the share price has lost 53.1%, trading between 12.57 and 31.50.
Tweenvest scores Vireo Growth Inc. across four factors: quality 44/100, value 68/100, growth 100/100. Its strongest factor is growth.
VREO price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $457.48M
- Revenue (TTM)
- $511.67M
- P/E
- —
- EPS
- -1.81
- Dividend yield
- —
- Beta (5Y)
- 0.17
- 52-week high
- CA$31.50
- 52-week low
- CA$12.57
- Avg volume (3M)
- —
- Shares outstanding
- 48.82M
- Employees
- 385
- Next earnings
- —
About Vireo Growth Inc.
Goodness Growth Holdings, Inc. operates as a physician-led cannabis company in the United States. The company cultivates cannabis in environmentally friendly greenhouses; manufactures pharmaceutical-grade cannabis extracts; and sells its products through its network of Green Goods and other Goodness Growth branded retail dispensaries, as well as third-party dispensaries. As of March 11, 2022, it operated 18 dispensaries, which included 2 in Maryland, 8 in Minnesota, 4 in New Mexico, and 4 in New York; and offered wholesale cannabis products through third-party companies in Arizona, Maryland, Minnesota, and New York. The company was formerly known as Vireo Health International Inc. and changed its name to Goodness Growth Holdings, Inc. in June 2021. Goodness Growth Holdings, Inc. is headquartered in Minneapolis, Minnesota.
- ISIN
- CA92767B2049
- Founded
- 2004
- Listed since
- May 17, 2005
- Exchange
- Canadian National Stock Exchange
- Currency
- CAD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| RPG Life Sciences LimitedNSEI: RPGLIFE | $464.69M | Rs2,719.20 | -7.22% |
| Tuoxin Pharmaceutical Group Co.,Ltd.SZSE: 301089 | $464.38M | CN¥24.58 | +0.33% |
| Myung In Pharmaceutical LTD.KOSE: A317450 | $462.09M | ₩42,550.00 | -2.52% |
| Shanghai Kai Kai Industry Company LimitedSHSE: 600272 | $461.00M | CN¥15.65 | +4.26% |
| iX Biopharma Ltd.Catalist: 42C | $452.33M | S$0.53 | -5.36% |
| DHG Pharmaceutical Joint Stock CompanyHOSE: DHG | $450.55M | ₫89,200.00 | -0.22% |
| Jiangxi Synergy Pharmaceutical Co., Ltd.SZSE: 300636 | $448.91M | CN¥7.16 | +0.99% |
| JW Pharmaceutical CorporationKOSE: A001060 | $447.47M | ₩26,350.00 | -1.50% |
Figures last refreshed Oct 11, 2026.